Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group

Autor: T M, Beck, M, York, A, Chang, R, Navari, W H, Harvey, M, Meshad, D, Griffin, A, Wentz

Publikováno v: Cancer investigation. 15(4)

The efficacy and safety of ondansetron 8 mg BID compared with 8 mg TID for 3 days in the prevention of nausea and vomiting in 402 patients on cyclophosphamide (or = 500 mg/m2)-based chemotherapy were evaluated in a multicenter, randomized, double-bli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3c81cc467eb8cf89b15a81a140be9ba8
https://pubmed.ncbi.nlm.nih.gov/9679537

Zobrazit plný text záznamu

Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience

Autor: D M, Paul, A M, Garrett, M, Meshad, R D, DeVore, L L, Porter, D H, Johnson

Publikováno v: Seminars in oncology. 23(1 Suppl 1)

Paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) is an effective drug in the treatment of metastatic breast cancer (MBC). In the salvage setting, 5-fluorouracil (5-FU) and folinic acid have proved to be effective against MBC as well. R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d1b09036385b1ce0b117305304d73a05
https://pubmed.ncbi.nlm.nih.gov/8629038

Zobrazit plný text záznamu

Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group

Autor: L X, Cubeddu, K, Pendergrass, T, Ryan, M, York, G, Burton, M, Meshad, D, Galvin, A A, Ciociola

Publikováno v: American journal of clinical oncology. 17(2)

We evaluated the efficacy and safety of oral ondansetron, a selective antagonist of 5-HT3 receptors, for the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapy (500 mg/m2). In this trial 324 chemotherapy-naive cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3876e86e06619283073b63dc35997cee
https://pubmed.ncbi.nlm.nih.gov/8141106

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cryosurgery in cutaneous leishmaniasis

Autor: A. BASSIOUNY, M. MESHAD, M. TALAAT, K. KUTTY, B. METAWAA

Publikováno v: The British journal of dermatology. 107(4)

SUMMARY Thirty patients with cutaneous leishmaniasis were treated with cryotherapy using a CO2 cryomachine and all were cured without noticeable scarring within 4–5 weeks, with no relapse. Histopathological examination showed that cryotherapy eradi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3208dd2ea014f73c793f482065905ad
https://pubmed.ncbi.nlm.nih.gov/7126453

Zobrazit plný text záznamu

Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM)

Autor: T J, Ervin, R, Weichselbaum, D, Miller, M, Meshad, M, Posner, R, Fabian

Publikováno v: Cancer treatment reports. 65(9-10)

Twenty-nine of 32 patients with advanced squamous cell carcinoma of the head and neck were treated with two courses of an intensive chemotherapy regimen consisting of cisplatin, bleomycin, and methotrexate (PBM). The frequency of toxic effects (in 29

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0f293389b109c892f0da29e47e1eb071
https://pubmed.ncbi.nlm.nih.gov/6168371

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání